New study monitors Takhzyro's Real-World safety for rare swelling disorder

NCT ID NCT07445087

Not yet recruiting Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen Mar 30, 2026 · Last updated May 13, 2026 · Updated 8 times

Summary

This study looks at how safe and effective Takhzyro is for teenagers and adults with hereditary angioedema (HAE) in everyday medical care in South Korea. HAE is a rare condition that causes sudden swelling under the skin or inside the body. The study will track side effects and how well the medicine controls swelling attacks. About 35 participants will be treated by their regular doctors as part of normal care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.